ZMB Member Ken Herrmann

ZMB Member
Ken Herrmann

Next ZMB-Member
Ken Herrmann portrait
© UDE

Prof. Dr. Ken Herrmann

University Hospital Essen
Hufelandstr. 55
45122 Essen

Research Overview

  • Development, application of new radiopharmaceuticals
  • Diagnosis and therapy of thyroid carcinoma
  • Diagnostics and therapy of endocrine tumors
  • Diagnostics and therapy of prostate cancer
  • Clinical use, optimization of PET, PET / CT

Read more

Selected Publications

    Journal articles

  • Pasquier, David; Bidaut, Luc; Oprea-Lager, Daniela Elena; deSouza, Nandita M; Krug, David; Collette, Laurence; Kunz, Wolfgang; Belkacemi, Yazid; Bau, Maria Grazia; Caramella, Caroline; De Geus-Oei, Lioe-Fee; De Caluwé, Alex; Deroose, Christophe; Gheysens, Olivier; Herrmann, Ken; Kindts, Isabelle; Kontos, Michalis; Kümmel, Sherko; Linderholm, Barbro; Lopci, Egesta; Meattini, Icro; Smeets, Ann; Kaidar-Person, Orit; Poortmans, Philip; Tsoutsou, Pelagia; Hajjaji, Nawale; Russell, Nicola; Senkus, Elżbieta; Talbot, Jean-Noël; Umutlu, Lale; Vandecaveye, Vincent; Verhoeff, Joost J C; van Oordt, Willemien Menke-van der Houven; Zacho, Helle D; Cardoso, Fatima; Fournier, Laure; Van Duijnhoven, Frederieke; Lecouvet, Frédéric E
    Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer : a consensus recommendation from the EORTC Imaging and Breast Cancer Groups
    In: The Lancet Oncology Vol. 24 (2023) Nr. 8, pp. e331 - e343
  • Fizazi, Karim; Herrmann, Ken; Krause, Bernd J; Rahbar, Kambiz; Chi, Kim N; Morris, Michael J; Sartor, Oliver; Tagawa, Scott T; Kendi, Ayse T; Vogelzang, Nicholas; Calais, Jeremie; Nagarajah, James; Wei, Xiao X; Koshkin, Vadim S; Beauregard, Jean-Mathieu; Chang, Brian; Ghouse, Ray; DeSilvio, Michelle; Messmann, Richard A; de Bono, Johann
    Health-related quality of life and pain outcomes with [¹⁷⁷Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION) : a multicentre, open-label, randomised, phase 3 trial
    In: The Lancet Oncology Vol. 24 (2023) Nr. 6, pp. 597 - 610
  • Weber, Manuel; Kersting, David; Riemann, Burkhard; Brandenburg, Tim; Führer, Dagmar; Grünwald, Frank; Kreissl, Michael C.; Dralle, Henning; Weber, Frank; Schmid, Kurt Werner; Herrmann, Ken; Jentzen, Walter; Grafe, Hong; Rischpler, Christoph; Theurer, Sarah; Bockisch, Andreas; Nagarajah, James; Fendler, Wolfgang
    Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI) : A Single-Center Prospective Two-Arm Study
    In: Clinical Cancer Research Vol. 28 (2022) Nr. 19, pp. 4194 - 4202
  • Seifert, Robert; Kersting, David; Rischpler, Christoph; Sandach, Patrick; Ferdinandus, Justin; Fendler, Wolfgang; Rahbar, Kambiz; Weckesser, Matthias; Umutlu, Lale; Hanoun, Christine; Hüttmann, Andreas; Reinhardt, Hans Christian; von Tresckow, Bastian; Herrmann, Ken; Dührsen, Ulrich; Schäfers, Michael
    Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification : A post-hoc analysis of the PETAL trial
    In: Leukemia Vol. 36 (2022) Nr. 12, pp. 2845 - 2852
  • Bodei, Lisa; Herrmann, Ken; Schöder, Heiko; Scott, Andrew M.; Lewis, Jason S.
    Radiotheranostics in oncology : current challenges and emerging opportunities
    In: Nature Reviews Clinical Oncology Vol. 19 (2022) Nr. 8, pp. 534 - 550
  • Fendler, Wolfgang; Pabst, Kim M.; Kessler, Lukas; Fragoso Costa, Pedro; Ferdinandus, Justin; Weber, Manuel; Lippert, Maria; Lückerath, Katharina; Umutlu, Lale; Kostbade, Karina; Mavroeidi, Ilektra A.; Schuler, Martin; Ahrens, Marit; Rischpler, Christoph; Bauer, Sebastian; Herrmann, Ken; Siveke, Jens; Hamacher, Rainer
    Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities
    In: Clinical Cancer Research Vol. 28 (2022) Nr. 19, pp. 4346 - 4353
  • Hope, Thomas A.; Eiber, Matthias; Armstrong, Wesley R.; Juarez, Roxanna; Murthy, Vishnu; Lawhn-Heath, Courtney; Behr, Spencer C.; Zhang, Li; Barbato, Francesco; Ceci, Francesco; Farolfi, Andrea; Schwarzenböck, Sarah M.; Unterrainer, Marcus; Zacho, Helle D.; Nguyen, Hao G.; Cooperberg, Matthew R.; Carroll, Peter R.; Reiter, Robert E.; Holden, Stuart; Herrmann, Ken; Zhu, Shaojun; Fendler, Wolfgang; Czernin, Johannes; Calais, Jeremie
    Diagnostic Accuracy of ⁶⁸Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection : A Multicenter Prospective Phase 3 Imaging Trial
    In: JAMA Oncology Vol. 7 (2021) Nr. 11, pp. 1635 - 1642
  • Gafita, Andrei; Calais, Jeremie; Grogan, Tristan R.; Hadaschik, Boris; Wang, Hui; Weber, Manuel; Sandhu, Shahneen; Kratochwil, Clemens; Esfandiari, Rouzbeh; Tauber, Robert; Zeldin, Anna; Rathke, Hendrik; Armstrong, Wesley R.; Robertson, Andrew; Thin, Pan; D'Alessandria, Calogero; Rettig, Matthew B.; Delpassand, Ebrahim S.; Haberkorn, Uwe; Elashoff, David; Herrmann, Ken; Czernin, Johannes; Hofman, Michael S.; Fendler, Wolfgang; Eiber, Matthias
    Nomograms to predict outcomes after ¹⁷⁷Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer : An international, multicentre, retrospective study
    In: The Lancet Oncology Vol. 22 (2021) Nr. 8, pp. 1115 - 1125
  • Herrmann, Ken; Kraus, Bernd Joachim; Hadaschik, Boris; Kunikowska, Jolanta; van Poppel, Hendrik; N'Dow, James; Sartor, Oliver; Oyen, Wim J. G.
    Nuclear medicine theranostics comes of age
    In: The Lancet Oncology Vol. 22 (2021) Nr. 11, pp. 1497 - 1498
  • Kollenda, Sebastian; Klose, Jasmin; Knuschke, Torben; Sokolova, Viktoriya; Schmitz, Jochen; Staniszewska, Magdalena; Costa, Pedro Fragoso; Herrmann, Ken; Westendorf, Astrid; Fendler, Wolfgang; Epple, Matthias
    In vivo biodistribution of calcium phosphate nanoparticles after intravascular, intramuscular, intratumoral, and soft tissue administration in mice investigated by small animal PET/CT
    In: Acta Biomaterialia Vol. 109 (2020) pp. 244 - 253
  • Bodei, Lisa; Schöder, Heiko; Baum, Richard P; Herrmann, Ken; Strosberg, Jonathan; Caplin, Martyn; Öberg, Kjell; Modlin, Irvin M
    Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy
    In: The Lancet Oncology Vol. 21 (2020) Nr. 9, pp. e431 - e443
  • Herrmann, Ken; Schwaiger, Markus; Lewis, Jason S.; Solomon, Stephen B.; McNeil, Barbara J.; Baumann, Michael; Gambhir, Sanjiv S.; Hricak, Hedvig; Weissleder, Ralph
    Radiotheranostics : A roadmap for future development
    In: The Lancet Oncology Vol. 21 (2020) Nr. 3, pp. e146 - e156
  • Fendler, Wolfgang P.; Calais, Jeremie; Eiber, Matthias; Flavell, Robert R.; Mishoe, Ashley; Feng, Felix Y.; Nguyen, Hao G.; Reiter, Robert E.; Rettig, Matthew B.; Okamoto, Shozo; Emmett, Louise; Zacho, Helle D.; Ilhan, Harun; Wetter, Axel; Rischpler, Christoph; Schoder, Heiko; Burger, Irene A.; Gartmann, Jeannine; Smith, Raven; Small, Eric J.; Slavik, Roger; Carroll, Peter R.; Herrmann, Ken; Czernin, Johannes; Hope, Thomas A.
    Assessment of ⁶⁸Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer : A Prospective Single-Arm Clinical Trial
    In: JAMA Oncology Vol. 5 (2019) Nr. 6, pp. 856 - 863
  • Schotten, Clemens; Bechmann, Lars Peter; Manka, Paul; Theysohn, Jens; Dechene, Alexander; El Fouly, Amr; Barbato, Francesco; Neumann, Ursula; Radünz, Sonia; Sydor, Svenja; Heider, Dominik; Venerito, Marino; Canbay, Aliekber; Gerken, Guido; Herrmann, Ken; Wedemeyer, Heiner; Best, Jan; Bechmann, Lars P.; El Fouly, Amr
    NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization
    In: Liver Cancer Vol. 8 (2019) Nr. 6, pp. 491 - 504
  • Fendler, Wolfgang P.; Weber, Manuel; Iravani, Amir; Hofman, Michael S.; Calais, Jeremie; Czernin, Johannes; Ilhan, Harun; Saad, Fred; Small, Eric J.; Smith, Matthew R.; Perez, Paola M.; Hope, Thomas A.; Rauscher, Isabel; Londhe, Anil; Lopez-Gitlitz, Angela; Cheng, Shinta; Maurer, Tobias; Herrmann, Ken; Eiber, Matthias; Hadaschik, Boris
    Prostate-specific membrane antigen ligand positron emission tomography in men with nonmetastatic castration-resistant prostate cancer
    In: Clinical Cancer Research Vol. 25 (2019) Nr. 24, pp. 7448 - 7454
  • Gerwing, Mirjam; Herrmann, Ken; Helfen, Anne; Schliemann, Christoph; Berdel, Wolfgang E.; Eisenblätter, Michel; Wildgruber, Moritz
    The beginning of the end for conventional RECIST — novel therapies require novel imaging approaches
    In: Nature Reviews Clinical Oncology Vol. 16 (2019) Nr. 7, pp. 442 - 458
  • Fanti, Stefano; Minozzi, Silvia; Antoch, Gerald; Banks, Ian; Briganti, Alberto; Carrio, Ignasi; Chiti, Arturo; Clarke, Noel; Eiber, Matthias; De Bono, Johann; Fizazi, Karim; Gillessen, Silke; Gledhill, Sam; Haberkorn, Uwe; Herrmann, Ken; Hicks, Rodney J.; Lecouvet, Frederic; Montironi, Rodolfo; Ost, Piet; O'Sullivan, Joe M.; Padhani, Anwar R.; Schalken, Jack A.; Scher, Howard I.; Tombal, Bertrand; van Moorselaar, Reindert Jeroen A.; Van Poppel, Heindrik; Vargas, Hebert Alberto; Walz, Jochen; Weber, Wolfgang A.; Wester, Hans-Jürgen; Oyen, Wim J.G.
    Consensus on molecular imaging and theranostics in prostate cancer
    In: The Lancet Oncology Vol. 19 (2018) Nr. 12, pp. e696 - e708
  • Schotten, C.; Bechmann, Lars Peter; Manka, Paul; Theysohn, Jens; Dechene, Alexander; El Fouly, A.; Muller, S.; Schulze, Maren; Neumann, U.; Radunz, S.; Heider, Dominik; Canbay, Aliekber; Gerken, Guido; Herrmann, Ken; Wedemeyer, Heiner; Best, Jan
    Extrahepatic Comorbidities Do Not Alter the Safety and Efficacy of Radioembolization of NAFLD-Associated HCC
    In: Hepatology Vol. 68 (2018) Nr. Suppl. 1, pp. 852A - 853A
  • Lecouvet, Frédéric E.; Oprea-Lager, Daniela E.; Liu, Yan; Ost, Piet; Bidaut, Luc; Collette, Laurence; Deroose, Christophe M.; Goffin, Karolien; Herrmann, Ken; Hoekstra, Otto S.; Kramer, Gem; Lievens, Yolande; Lopci, Egesta; Pasquier, David; Petersen, Lars J.; Talbot, Jean-Noël; Zacho, Helle; Tombal, Bertrand; deSouza, Nandita M.
    Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer : a consensus recommendation from the EORTC Imaging Group
    In: The Lancet Oncology Vol. 19 (2018) Nr. 10, pp. e534 - e545
  • Caldarelli, Antonio; Müller, Jörg P.; Paskowski-Rogacz, M.; Herrmann, Ken; Bauer, Reinhard F.; Koch, Sina; Heninger, Anne Kristin; Krastev, Dragomir Blazhev; Ding, Li; Kasper, Stefan; Fischer, Thomas A.; Brodhun, Michael; Böhmer, Frank Dietmar; Buchholz, Frank
    A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling
    In: Leukemia Vol. 27 (2013) Nr. 12, pp. 2301 - 2310